Impact ledger
Neumora Therapeutics, Inc. (NMRA)
5 events mapped to this ticker since 2026-06-15.
Assumption changes
| Date | Assumption | Direction | Magnitude | Conf. |
|---|---|---|---|---|
| 2026-06-15 | net_debt | Bearish | 10000000.00 | 0.90 |
| 2026-06-15 | revenue | Bearish | — | 1.00 |
| 2026-06-15 | share_count | Bullish | — | 0.70 |
| 2026-06-15 | net_debt | Bullish | — | 0.70 |
| 2026-06-15 | revenue | Bullish | — | 0.70 |
| 2026-06-15 | net_debt | Bearish | 10000000.00 | 0.90 |
| 2026-06-15 | net_debt | Bearish | — | 0.70 |
| 2026-06-15 | interest_expense | Bearish | — | 0.70 |
Event impact log
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-06-16 | Event | Direct impact of pipeline failure, cost restructuring, and cash runway extension. | mixed | 1-3m | 0.70 |
| 2026-06-15 | Event | Direct announcement of a material definitive agreement or completed acquisition, which could be positive (e.g., strategic partnership, accretive acquisition) or negative (e.g., dilutive acquisition, unfavorable licensing deal). | watch | 1-5d | 0.80 |
| 2026-06-15 | Event | Direct impact from potential acquisition or significant agreement. The nature of the agreement (e.g., acquisition, licensing deal, partnership) will dictate the specific financial implications. | watch | 1-3m | 0.80 |
| 2026-06-15 | Event | Direct impact of failed clinical trial on pipeline value and investor sentiment, partially offset by cost-cutting measures. | Bearish | 1-3m | 0.90 |
| 2026-06-15 | Event | Direct impact of clinical trial failure, asset discontinuation, and workforce reduction on company's pipeline, operational costs, and investor sentiment. | Bearish | 1-3m | 0.90 |
This ledger is regenerated from Market Ontology's public event pipeline. For live alerts on new assumption changes for NMRA, start a trial or view the NMRA entity page.